Journal article
Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors
Abstract
Purpose of ReviewBruton's tyrosine kinase inhibitors (BTKis) have changed the treatment and prognosis of several B-cell malignancies. However, since the approval of the first BTKi, ibrutinib, reports of cardiovascular adverse events especially atrial fibrillation have arisen. In this review, we discuss the cardiovascular side effects of BTKis and the management of these toxicities in clinical practice.Recent FindingsBTKIs increase the risks of …
Authors
Aghel N; Baro Vila RC; Lui M; Hillis C; Leong DP
Journal
Current Cardiology Reports, Vol. 25, No. 9, pp. 941–958
Publisher
Springer Nature
Publication Date
September 2023
DOI
10.1007/s11886-023-01916-4
ISSN
1523-3782